期刊文献+

miR-150对降植烷诱导的狼疮鼠肺出血的影响 被引量:2

Influence of miR-150 on pulmonary hemorrhage in pristane-induced murine lupus model
原文传递
导出
摘要 本研究旨在观察miR-150在降植烷诱导的狼疮鼠中对肺出血的发生和严重程度的影响并初步探讨其可能的机制。实验选用8周龄C57/B6小鼠和miR-150基因缺陷小鼠,腹腔注射降植烷(pristane),在注射后的第7天、第10天、第14天观察肺脏大体病理变化,苏木素-伊红(HE)染色观察肺组织病理变化并进行病理评分。发现注射降植烷第10天和(或)第14天后C57/B6组和miR-150缺陷小鼠组均发生不同程度的肺出血,后者的严重程度大于前者。肺组织病理评分显著升高;miR-150缺陷组与C57/B6组比较血浆TNF-α表达升高,右肺上叶组织湿干比值(W/D)也显著升高。提示在降植烷诱导的狼疮鼠模型中miR-150参与了肺出血的发病过程,miR-150有望成为预测狼疮肺出血的生物标记物。 To investigate the effect of miR-150 on pulmonary hemorrhage in pristane-induced murine lupus model and to explore the possible mechanism,C57/B6 mice and miR-150-deficient mice received a single dose of 0.5 ml pristane intraperitoneally at eight-weeks old.After 7 days,10 days,14 days,pulmonary hemorrhage was investigated by gross pathology and hematoxylin-eosin stain scores.We found that both C57/B6 group and miR-150-deficient group suffered pulmonary hemorrhage,and miR-150-deficient group was more serious than C57/B6 group 10 days and 14 days after injection of pristane.In addition,compared to C57/B6 group,its histological score is higher.Then,the quantification of TNF-α in serum was performed by sandwich enzymed-linked immune absorbent assay(ELISA) and the right upper lobe of the lung was weighted before and after drying.Results showed that expression of TNF-α in the serum and W/D ratio of miR-150-deficient group was higher revealing that miR-150 participates the pathogenesis of pulmonary hemorrhage in pristane-induced murine lupus model and hopefully be a forcasting biomarker of pulmonary hemorrhage of lupus.
出处 《现代免疫学》 CAS CSCD 北大核心 2012年第3期182-186,共5页 Current Immunology
基金 国家自然科学基金资助项目(30700734 30801026 30971632)
关键词 微小RNA miR-150 系统性红斑狼疮 肺出血 microRNA miR-150 systemic lupus erythematosus pulmonary hemorrhage
  • 相关文献

参考文献17

  • 1Todd DJ, Costenbader KH. Dyspnoea in a young woman with active systemic lupus erythematosus[J]. Lupus, 2009, 18:777-784.
  • 2Santos-Ocampo AS, Mandell BF, Fessler BJ. Alveolar hem- orrhage in systemic lupus erythematosus: presentation and management[J]. Chest, 2000,118:1083-1090.
  • 3Zamora MR, Warner ML, Tuder R, et al. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome[J]. Medi- eine (Baltimore), 1997,76 : 192-202.
  • 4Cordier JF, Cottin V. Alveolar hemorrhage in vasculitis.. primary and secondary semin respir[J]. Crit Care Med, 2011,32:310-321.
  • 5Kwok SK, Moon SJ, Ju JH, etal. Diffuse alveolar hemor- rhage in systemic lupus erythernatosus : risk factors and clini cal outcome: results from affiliated hospitals of Catholic Uni- versity of Korea[J]. Lupus, 2011,20 : 102-107.
  • 6崔广梅,刘钢.狼疮鼠模型的研究进展[J].中华风湿病学杂志,2003,7(9):548-550. 被引量:2
  • 7Barker TT, Lee PY, Kelly-Seumpia KM, et al. Pathogenic role of B cells in the development of diffuse alveolar emor- rhage induced by pristine[J]. Lab Invest, 2011,91,1540- 1550.
  • 8Xiao C, Calado DP, Galler G, etal. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb [J]. Cell, 2007,131:146-159.
  • 9Vasileseu C, Rossi S, Shimizu M, et al. MieroRNA finger- prints identify miR-150 as a plasma prognostic marker in patients with sepsis[J]. PLoS One, 2009,10: 7405,.
  • 10Watanabe A, Tagawa H, Yamashita J, et al. The role of microRNA-150 as a tumor suppressor in malignant lympho- ma[J]. Leukemia, 2011,25 : 1324-1334.

二级参考文献67

  • 1崔慧娟,唐元家,罗晓兵,邓筠,郭彦芝,黄新芳,陈顺乐,沈南.系统性红斑狼疮患者中miR-146a表达缺陷与I型干扰素通路过度活化相关[J].现代免疫学,2008,28(4):279-284. 被引量:13
  • 2华晶,沈南,陈顺乐.Ly-6E与系统性红斑狼疮[J].现代免疫学,2004,24(5):435-436. 被引量:1
  • 3[10]Yu P,Wellmann U,Kunder S,et al.Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE[J].Int Immunol,2006,18(8):1211-1219.
  • 4[11]Papadimitraki ED,Choulaki C,Koutala E,et al.Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus:implications for the induction and maintenance of the autoimmune process[J].Arthritis Rheum,2006,54(11):3601-3611.
  • 5[12]Han GM,Chen SL,Shen N,et al.Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray[J].Genes Immun,2003,4(3):175-176.
  • 6[15]Feng X,Wu H,Grossman JM,et al.Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus[J].Arthritis Rheum,2006,54(9):2951-2962.
  • 7[16]Calin GA,Croce CM.Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance[J].Semin Oncol,2006,33(2):167-173.
  • 8[17]Porkka KP,Pfeiffer MJ,Waltering KK,et al.MicroRNA expression profiling in prostate cancer[J].Cancer Res,2007,67(13):6130-6135.
  • 9[18]Dai Y,Huang YS,Tang M,et al.Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients[J].Lupus,2007,16(12):939-946.
  • 10[1]Ambros V.The functions of animal microRNAs[J].Nature,2004,431(7006):350-355.

共引文献22

同被引文献30

  • 1Rongxiu Huo,Xinxiang Huang,Jinying Lin.Systemic lupus erythematosus with diffuse alveolar hemorrhage[J].Chinese Medical Journal,2023,136(23):2883-2885. 被引量:1
  • 2Levy DE, Garcia-Sastre A. The virus battles: IFN inductionof the antiviral state and mechanisms of viral evasion [J].Cytokine Growth Factor Rev, 2001,12: 143-156.
  • 3Samuel CE. Antiviral actions of interferons[J]. Clin Microbi-ol Rev, 2001, 14: 778-809.
  • 4Dalton DK, Pitts-Meek S, Keshav S,et al. Multiple defectsof immune cell function in mice with disrupted interferon-gamma genes[J]. Science, 1993,259 : 1739-1742.
  • 5Bach EA, Aguet M, Schreiber RD, et al. The IFN-gammareceptor: a paradigm for cytokine receptor signaling [J]. An-nu Rev Immunol, 1997,15: 563-591.
  • 6Biron CA. Interferons alpha and beta as immune regulators一a new look [J], Immunity, 2001,14: 661-664.
  • 7Le Bon A, Tough DF. Links between innate and adaptive im-munity via type I interferon[J]. Curr Opin Immunol,2002,14: 432-436.
  • 8Pestka S, Krause CD, Walter MR, et al. Interferons, inter-feron-like cytokines, and their receptors [J]. Immunol Rev,2004,202: 8-32.
  • 9Kotenko SV, Gallagher G, Baurin VV, et al. IFN-lambdasmediate antiviral protection through a distinct class II cyto-kine receptor complex[J], Nat Immunol, 2003,4 . 69-77.
  • 10Sheppard P, Kindsvogel W, Xu W, et al. IL-28,IL-29 andtheir class II cytokine receptor IL-28R [J]. Nat Immunol.2003, 4: 63-68.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部